Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$1.74 - $2.4 $328,191 - $452,678
-188,616 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$2.08 - $3.6 $247,158 - $427,773
-118,826 Reduced 38.65%
188,616 $409,000
Q2 2021

Aug 12, 2021

SELL
$3.36 - $10.56 $1.34 Million - $4.22 Million
-400,000 Reduced 56.54%
307,442 $1.08 Million
Q1 2021

May 13, 2021

SELL
$9.26 - $14.36 $1.39 Million - $2.16 Million
-150,558 Reduced 17.55%
707,442 $6.98 Million
Q3 2020

Nov 12, 2020

BUY
$10.3 - $21.64 $1.6 Million - $3.35 Million
155,000 Added 22.05%
858,000 $8.84 Million
Q2 2020

Aug 13, 2020

SELL
$8.53 - $25.64 $971,950 - $2.92 Million
-113,945 Reduced 13.95%
703,000 $14.7 Million
Q1 2020

May 13, 2020

BUY
$7.98 - $16.32 $2.29 Million - $4.68 Million
287,000 Added 54.16%
816,945 $7.98 Million
Q4 2019

Feb 12, 2020

SELL
$5.12 - $12.22 $233,984 - $558,454
-45,700 Reduced 7.94%
529,945 $6.11 Million
Q3 2019

Nov 13, 2019

SELL
$5.24 - $15.89 $202,022 - $612,623
-38,554 Reduced 6.28%
575,645 $3.14 Million
Q2 2019

Aug 13, 2019

SELL
$5.1 - $11.89 $1.4 Million - $3.26 Million
-274,523 Reduced 30.89%
614,199 $7.3 Million
Q1 2019

May 13, 2019

SELL
$3.03 - $6.02 $1.2 Million - $2.39 Million
-396,678 Reduced 30.86%
888,722 $4.66 Million
Q4 2018

Feb 12, 2019

BUY
$2.87 - $5.92 $388,598 - $801,568
135,400 Added 11.77%
1,285,400 $4.05 Million
Q3 2018

Nov 13, 2018

BUY
$4.5 - $7.6 $5.18 Million - $8.74 Million
1,150,000 New
1,150,000 $6.96 Million

Others Institutions Holding ADVM

About Adverum Biotechnologies, Inc.


  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Ws Management Lllp Portfolio

Follow Ws Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Ws Management Lllp with notifications on news.